CN120417894A - 脑神经细胞保护用组合物 - Google Patents

脑神经细胞保护用组合物

Info

Publication number
CN120417894A
CN120417894A CN202380089042.4A CN202380089042A CN120417894A CN 120417894 A CN120417894 A CN 120417894A CN 202380089042 A CN202380089042 A CN 202380089042A CN 120417894 A CN120417894 A CN 120417894A
Authority
CN
China
Prior art keywords
composition
docosahexaenoic acid
acid
lutein
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380089042.4A
Other languages
English (en)
Chinese (zh)
Inventor
森田贤
末安俊明
安本启甫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of CN120417894A publication Critical patent/CN120417894A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202380089042.4A 2022-12-26 2023-12-19 脑神经细胞保护用组合物 Pending CN120417894A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2022208134 2022-12-26
JP2022-208134 2022-12-26
JP2023-061431 2023-04-05
JP2023061431 2023-04-05
PCT/JP2023/045395 WO2024143060A1 (ja) 2022-12-26 2023-12-19 脳神経細胞保護用組成物

Publications (1)

Publication Number Publication Date
CN120417894A true CN120417894A (zh) 2025-08-01

Family

ID=91717479

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380089042.4A Pending CN120417894A (zh) 2022-12-26 2023-12-19 脑神经细胞保护用组合物

Country Status (4)

Country Link
JP (1) JPWO2024143060A1 (enrdf_load_stackoverflow)
CN (1) CN120417894A (enrdf_load_stackoverflow)
TW (1) TW202434198A (enrdf_load_stackoverflow)
WO (1) WO2024143060A1 (enrdf_load_stackoverflow)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005443A1 (ja) * 2013-07-10 2015-01-15 ライオン株式会社 内服組成物
CN110691590A (zh) * 2017-06-01 2020-01-14 参天制药株式会社 用于预防和/或改善脑功能障碍的含有叶黄素类或其盐和菱属植物的加工产物的组合物
GB201720119D0 (en) * 2017-12-04 2018-01-17 Howard Foundation Holdings Ltd Prevention and/or treatment of neurodegenerative disease

Also Published As

Publication number Publication date
WO2024143060A1 (ja) 2024-07-04
TW202434198A (zh) 2024-09-01
JPWO2024143060A1 (enrdf_load_stackoverflow) 2024-07-04

Similar Documents

Publication Publication Date Title
JP5985138B2 (ja) エネルギー消費促進剤
EP3483256A1 (en) Akkermansia muciniphila strain having effect of preventing or treating degenerative brain diseases or metabolic diseases, and use thereof
KR102038810B1 (ko) 성장 호르몬 분비 촉진제
US20090047304A1 (en) Composition For Body Fat Reduction
HUE028065T2 (en) Preparations for the treatment of neurological disorders
US20120309716A1 (en) Motor Function Improver
US20160067270A1 (en) Use of ginsenoside f2 for prophylaxis and treatment of liver disease
JP5594819B2 (ja) 脂質代謝改善用組成物
JPH11246399A (ja) 脂質代謝改善組成物
JP5071618B2 (ja) 外分泌腺の機能障害改善剤及び機能障害改善用飲食物
KR100828069B1 (ko) 푸코잔틴 또는 이를 함유하는 해조류 추출물을 포함하는,지방간의 예방 또는 치료용 조성물
WO2021230145A1 (ja) ニコチンアミドアデニンジヌクレオチド（ｎａｄ）濃度上昇剤
JP5985226B2 (ja) 過活動膀胱の予防又は改善剤
DE69524024T2 (de) Präventives oder Linderung-Mittel für medischen Symptomen verursacht durch verzögerte Allergie-Reaktionen
JP2010105946A (ja) 筋タンパク質増強剤及びこれを含む医薬品または食品
JP7229513B2 (ja) 脳の機能改善剤および脳の機能改善用飲食品
CN120417894A (zh) 脑神经细胞保护用组合物
KR101174301B1 (ko) 유황을 섭취한 파리 유충 추출물을 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 조성물
JP4672304B2 (ja) 脂肪分解促進剤
JP5196708B2 (ja) アスタキサンチン及び／又はそのエステルを有効成分とする筋萎縮改善剤及び飲食物
CN109153693B (zh) 安全－稳定的缩醛磷脂和其制剂及认知症的未病状态的判断方法
JP4997514B2 (ja) 血圧上昇抑制剤
WO2023223943A1 (ja) 血管内皮機能改善用組成物
KR20090083263A (ko) 진저롤을 함유하는 알코올성 태아기형 예방 및 치료용조성물
TW202502321A (zh) 含有芝麻素類化合物及阿魏酸或其鹽之組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination